نتایج جستجو برای: renoprotection

تعداد نتایج: 483  

Journal: :Kidney & blood pressure research 2010
Tsukasa Nakamura Nobuharu Fujiwara Eiichi Sato Yoshihiko Ueda Takeshi Sugaya Hikaru Koide

BACKGROUND There is increasing evidence that inhibition of the renin-angiotensin system provides renoprotection independent of blood pressure lowering. The aim of the present study was to determine whether various angiotensin II receptor blockers (ARBs) affect urinary albumin excretion (UAE), urinary liver-type fatty acid-binding protein (L-FABP) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels ...

Journal: :Journal of pharmacological sciences 2012
Bai Lei Daisuke Nakano Yu-Yan Fan Kento Kitada Hirofumi Hitomi Hiroyuki Kobori Hirohito Mori Tsutomu Masaki Akira Nishiyama

We hypothesized that aliskiren provides renoprotection in diabetic animals that did not receive sufficient renoprotection by AT1-receptor antagonist treatment. Type 2 diabetic KKAy mice were treated with group 1: vehicle or group 2: valsartan (15 mg/kg per day) from 12 to 16 weeks of age. The mice were subsequently divided into 4 groups and treated with the following combinations of drugs for a...

Journal: :American journal of physiology. Renal physiology 2011
Carla Zoja Sara Cattaneo Fabio Fiordaliso Vincenzo Lionetti Vanessa Zambelli Monica Salio Daniela Corna Chiara Pagani Daniela Rottoli Cinzia Bisighini Giuseppe Remuzzi Ariela Benigni

Diabetic nephropathy is associated with cardiovascular morbidity. Angiotensin-converting enzyme (ACE) inhibitors provide imperfect renoprotection in advanced type 2 diabetes, and cardiovascular risk remains elevated. Endothelin (ET)-1 has a role in renal and cardiac dysfunction in diabetes. Here, we assessed whether combination therapy with an ACE inhibitor and ET(A) receptor antagonist provide...

Journal: :Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 2016
Cody Carson Akram Al-Makki Brian Shepler

PURPOSE To determine if there is sufficient evidence to recommend the addition of pentoxifylline to standard ACE inhibitor and ARB therapy in chronic kidney disease patients to reduce proteinuria and preserve kidney function.  METHODS A search of the literature was conducted using the PubMed.gov and ClinicalTrials.gov search engines and the search terms "pentoxifylline renoprotection", "pento...

2015
Claudio Bazzi Elena Tagliabue Sara Raimondi Virginia Rizza Daniela Casellato Masaomi Nangaku

Metabolic acidosis correction in advanced renal failure slows renal function decline attributed to tubulointerstitial damage (TID) reduction. No study evaluated if spontaneous baseline high urinary pH (UpH) is renoprotective in patients with normal renal function and without metabolic acidosis. The study tested this hypothesis in idiopathic membranous nephropathy (IMN). Eighty-five patients (fo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید